Levothyroxine ( DrugBank: Levothyroxine )

3 diseases

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01276782 (ClinicalTrials.gov)	January 2011	12/1/2011	Levothyroxine in Pregnant SLE Patients	Pilot Double-Blind Placebo Controlled Trial of Levothyroxinein Pregnant Systemic Lupus Erythematosus ...	Systemic Lupus Erythematosus	Drug: Levothyroxine	Johns Hopkins University	New York University School of Medicine;Duke University;University of Chicago;Stanford University	Withdrawn	18 Years	45 Years	Female	0	Phase 4	United States

臨床試験数 : 492 / 薬物数 : 341 - (DrugBank : 47) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 100

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2004-005184-15-GB (EUCTR)	24/05/2005	29/04/2005	Central Hypothyroidism and Adjusted Thyroxine dose Study (CHATS): impact of increasing free thyroxin ...	Central Hypothyroidism and Adjusted Thyroxine dose Study (CHATS): impact of increasing free thyroxin ...	Central (secondary/tertiary) hypothyroidism (subclinical)	Trade Name: Levothyroxine Product Name: Levothyroxine INN or Proposed INN: Levothyroxine	Christie Hospital NHS Trust	NULL	Not Recruiting			Female: yes Male: yes	80		United Kingdom

臨床試験数 : 1 / 薬物数 : 5 - (DrugBank : 3) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 3

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04868045 (ClinicalTrials.gov)	April 27, 2021	28/4/2021	Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer	Evaluation of The Development of Central Resistance to Thyroid Hormone After Prolonged Exposure to E ...	Thyroid Cancer	Drug: Thyrotropin Releasing Hormone (TRH);Drug: levothyroxine;Other: Hypothyroidism QOL questionnair ...	Memorial Sloan Kettering Cancer Center	NULL	Withdrawn	18 Years	N/A	All	0	Phase 1	United States